Home » Topics » BioWorld Science

BioWorld Science
RSS

MPI-8 selectively inhibits both SARS-CoV-2 MPro and the host cathepsin L

Dec. 28, 2021

Novel anti-CD19 CAR binds to a membrane-proximal domain of CD19 for treatment of B-cell malignancies

Dec. 28, 2021

BeiGene presents new IAP protein inhibitors

Dec. 28, 2021

Chengdu Kanghong Pharmaceutical patents thyroid hormone receptor agonists

Dec. 28, 2021

New GLP-1 receptor agonists described by Medshine Discovery, Hangzhou Sciwind Biosciences

Dec. 28, 2021

Shanghai Antengene discovers GTPase KRAS inhibitors

Dec. 28, 2021

ScinnoHub Pharmaceutical divulges inhibitors of RET, Src and BTK

Dec. 28, 2021

New method for nitroimidazole fluoroalkylation through a visible-light-prompted radical reaction

Dec. 28, 2021

Cyrus Biotechnology's SARS-CoV-2 decoy receptor retains efficacy against Omicron

Dec. 27, 2021

Phages help to combat bacteria, reduce antibiotic use

Dec. 27, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...